Drug Safety

Is the Principle of a Stable Heinrich Ratio a Myth?: A Multimethod Analysis
pp. 637-642(6)
Authors: Gallivan, Steve; Taxis, Katja; Bryony Dean Franklin,; Barber, Nick

A Benefit-Risk Assessment of Benzbromarone in the Treatment of Gout: Was its Withdrawal from the Market in the Best Interest of Patients?
pp. 643-665(23)
Authors: Lee, Ming-Han H.; Graham, Garry G.; Williams, Kenneth M.; Day, Richard O.

Effects of Stratification on Data Mining in the US Vaccine Adverse Event Reporting System (VAERS)
pp. 667-674(8)
Authors: Emily Jane Woo,; Ball, Robert; Burwen, Dale R.; Braun, M. Miles

Association Between Use of Acid-Suppressive Drugs and Risk of Gastric Cancer: A Nested Case-Control Study
pp. 675-684(10)
Authors: Tamim, Hani; Duranceau, André; Chen, Long-Qi; LeLorier, Jacques

Associations Between Venous Thromboembolism and Antipsychotics: A Study of the WHO Database of Adverse Drug Reactions
pp. 685-694(10)
Authors: Hägg, Staffan; Bate, Andrew; Stahl, Malin; Spigset, Olav

Influence of Chemical Structure on Hypersensitivity Reactions Induced by Antiepileptic Drugs: The Role of the Aromatic Ring
pp. 695-702(8)
Authors: Handoko, Kim B.; van Puijenbroek, Eugène P.; Bijl, Annemarie H.; Hermens, Walter A.J.J.; Zwart-van Rijkom, Jeannette E.F.; Hekster, Yechiel A.; Egberts, Toine C.G.

Drug-Related Deaths: An Analysis of the Italian Spontaneous Reporting Database
pp. 703-713(11)
Authors: Leone, Roberto; Sottosanti, Laura; Maria Luisa Iorio,; Santuccio, Carmela; Conforti, Anita; Sabatini, Vilma; Moretti, Ugo; Venegoni, Mauro

Safety of Efalizumab Therapy in Patients with Moderate to Severe Psoriasis: An Open-Label Extension of a Phase IIIb Trial
pp. 715-726(12)
Authors: Hamilton, Tiffani; Menter, Alan; Caro, Ivor; Compton, Peter; Sobell, Jeffrey; Papp, Kim A.